Cleophas Kyama | Human Papilloma Virus | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

Cleophas Kyama
Jomo Kenyatta University Of Agriculture And Technology
Research Profile
Affiliation Jomo Kenyatta University Of Agriculture And Technology
Country Kenya
Scopus ID 57216717397
Documents 65
Citations 2,698
h-index 29
Subject Area Human Papilloma Virus
Event Global Diseases Research Awards
ORCID 0000-0001-6459-1514

The Research Excellence Award recognizes distinguished scholarly achievement and sustained scientific contribution in the field of Human Papilloma Virus research. Cleophas Kyama, affiliated with Jomo Kenyatta University Of Agriculture And Technology in Kenya, has contributed to interdisciplinary biomedical investigations involving infectious diseases, epidemiology, diagnostics, and public health research. The researcher’s scholarly profile demonstrates a substantial publication record, notable citation performance, and measurable academic influence within international scientific literature.[1]

Abstract

This article presents an academic overview of Cleophas Kyama and the researcher’s eligibility for recognition through the Research Excellence Award under the Global Diseases Research Awards initiative. The profile highlights scholarly productivity, citation performance, research engagement in Human Papilloma Virus investigations, and contribution to public health-oriented scientific discourse. With a Scopus-indexed publication record and measurable citation influence, the researcher demonstrates sustained participation in disease-related biomedical research and collaborative scientific development.[1][2]

Keywords

Human Papilloma Virus, Biomedical Research, Public Health, Infectious Diseases, Scientific Publications, Epidemiology, Research Excellence Award, Citation Impact, Academic Recognition, Disease Research

Introduction

Contemporary biomedical research increasingly emphasizes interdisciplinary collaboration, evidence-based disease management, and translational scientific advancement. Researchers engaged in Human Papilloma Virus studies contribute to global understanding of viral pathogenesis, diagnostics, epidemiological surveillance, and preventive healthcare systems. Academic recognition programs such as the Global Diseases Research Awards acknowledge researchers who demonstrate long-term commitment to impactful scientific inquiry and publication excellence.[3]

Research Profile

The scholarly record of Cleophas Kyama indicates active engagement in scientific publication and research dissemination within biomedical and disease-oriented disciplines. The researcher’s Scopus profile documents 65 indexed publications alongside 2,698 citations and an h-index of 29, suggesting consistent citation visibility and ongoing relevance within the academic community.[1]

Research Contributions

Research activities associated with Cleophas Kyama have contributed to scientific understanding within the broader field of infectious disease and Human Papilloma Virus research. Such investigations commonly support improved diagnostic approaches, epidemiological assessments, and healthcare interventions designed to reduce disease burden in affected populations.[4]

Publications

The publication portfolio associated with Cleophas Kyama includes research articles indexed within internationally recognized scientific databases. The researcher’s scholarly work contributes to ongoing biomedical discourse related to infectious diseases, public health, and disease management.[1]

Research Impact

The researcher’s impact is also reflected through institutional affiliation, publication continuity, and participation in internationally accessible scientific databases. Such indicators support recognition within academic evaluation frameworks focused on scientific productivity, citation performance, and interdisciplinary contribution.[2]

Award Suitability

The Research Excellence Award under the Global Diseases Research Awards framework recognizes researchers who exhibit sustained scientific engagement, publication quality, and measurable scholarly influence. Based on the documented research profile, Cleophas Kyama demonstrates several characteristics aligned with the objectives of the award program.[3]

Conclusion

Cleophas Kyama represents an academically active researcher with demonstrated contributions to Human Papilloma Virus and disease-oriented biomedical investigations. The researcher’s publication metrics, citation indicators, and institutional affiliation collectively support recognition through the Research Excellence Award. Continued scholarly engagement and participation in internationally indexed research dissemination are likely to further strengthen the researcher’s scientific impact and contribution to global health research initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Cleophas Kyama, Author ID 57216717397. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216717397
  2. ORCID. (n.d.). ORCID profile of Cleophas Kyama.
    https://orcid.org/0000-0001-6459-1514
  3. Global Diseases Research Awards. (n.d.). Research Excellence Award guidelines and recognition framework.
    https://globaldiseases.org/
  4. Elbasyouni, A., Kyama, M. C., El-Shemy, H. A., & Mwitari, P. G. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE, 20(5), e0323680. https://doi.org/10.1371/journal.pone.0323680
  5. Elbasyouni, A., Kyama, M. C., El-Shemy, H. A., & Mwitari, P. G. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE, 20(5), e0323680. https://doi.org/10.1371/journal.pone.0323680

Samir Abbès | Mycotoxicology | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

Samir Abbès — Higher Institute of Biotechnology of Monastir

Research Profile
Affiliation Higher Institute of Biotechnology of Monastir
Country Tunisia
Scopus ID 13407983200
Documents 46
Citations 1471
h-index 24
Subject Area Mycotoxicology
Event Global Diseases Research Awards

The Research Excellence Award recognizes scholarly achievements and sustained scientific contributions within the interdisciplinary field of mycotoxicology and disease-related biosciences. Samir Abbès, affiliated with the Higher Institute of Biotechnology of Monastir, Tunisia, has contributed to scientific investigations concerning fungal toxins, food safety, toxicological assessment, and public health implications associated with mycotoxin exposure.[1] His academic profile demonstrates measurable research impact through peer-reviewed publications, citation performance, and collaborative scientific activity within international research networks.[2]

Abstract

This academic recognition profile documents the scholarly activities and scientific contributions of Samir Abbès in the field of mycotoxicology. The profile highlights research productivity, publication metrics, interdisciplinary collaboration, and scientific impact associated with toxicological investigations and food safety sciences. Particular emphasis is placed on the evaluation of fungal toxins, biological risk assessment, and disease-related environmental health research. Citation performance and bibliometric indicators further demonstrate sustained academic engagement and international research visibility.[1

Keywords

  • Mycotoxicology
  • Food Safety
  • Toxicology
  • Disease Research
  • Fungal Contamination
  • Biotechnology
  • Research Excellence Award
  • Global Diseases Research Awards

Introduction

Mycotoxicology represents a critical area of biomedical and environmental research due to the widespread occurrence of fungal toxins in agricultural products and food systems. Research in this discipline contributes to understanding toxin biosynthesis, contamination pathways, toxicological mechanisms, and public health risks. Samir Abbès has participated in scientific studies associated with toxin monitoring, toxicological analysis, and preventive biotechnology approaches related to foodborne diseases and contamination risks.[2]

Research Profile

Samir Abbès is affiliated with the Higher Institute of Biotechnology of Monastir in Tunisia and has developed a scholarly profile focused on toxicological sciences, fungal contamination analysis, and food safety research. Bibliometric records indexed through Scopus identify 46 scholarly documents associated with the author profile and an h-index of 24, indicating sustained citation influence within the scientific community.[1]

Research Contributions

The research contributions associated with Samir Abbès primarily address toxicological assessments of mycotoxins and their implications for food quality and human health. Scientific investigations in this field commonly involve analytical detection methods, exposure evaluation, toxicological pathways, and mitigation strategies intended to reduce contamination risks.[5]

Publications

Selected research publications and indexed scholarly outputs demonstrate engagement with toxicological and bioscience research topics. Representative publication themes include fungal toxin characterization, toxic effects analysis, and biotechnology applications in food safety monitoring.[2]

Research Impact

Bibliometric indicators demonstrate measurable academic impact associated with the research profile. Citation metrics and h-index performance indicate that published studies have contributed to scientific dialogue and have been referenced within international research literature. Such indicators are commonly used to evaluate research visibility, influence, and scholarly dissemination.[1]

Award Suitability

The scholarly profile of Samir Abbès aligns with the objectives of the Global Diseases Research Awards due to demonstrated contributions in toxicology, disease-related bioscience, and environmental health research. Publication productivity, citation performance, interdisciplinary engagement, and sustained scientific activity collectively support consideration for research excellence recognition.

Conclusion

Samir Abbès has established a research profile characterized by scientific contributions in mycotoxicology, toxicological assessment, and food safety sciences. Bibliometric indicators, publication activity, and interdisciplinary engagement demonstrate sustained participation in internationally relevant scientific research. The Research Excellence Award profile reflects scholarly achievements associated with disease-related bioscience investigations and environmental health studies.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Samir Abbès, Author ID 13407983200. Scopus
    .https://www.scopus.com/authid/detail.uri?authorId=13407983200
  2. Global Diseases Research Awards. (n.d.). Research Excellence Award program overview
    .    https://globaldiseases.org/
  3. Zinedine, A., Durand, N., Meile, J.-C., Abbès, S., Ben Salah-Abbès, J., & Brabet, C. (2025). Determination of 22 mycotoxins in wheat grains cultivated in two Moroccan climatic areas by UHPLC-MS/MS. Food Chemistry, 495, 146356.
    https://doi.org/10.1016/j.foodchem.2025.146356
  4. Dhif, H., Ben Salah-Abbès, J., Abbès, S., Calleja-Gómez, M., Pallarés, N., & Berrada, H. (2025). Comparative study of phenolic profile and antioxidant activities of different parts of Ziziphus lotus using aqueous, hydroalcoholic and pulsed electric field extractions. Microchemical Journal, Article 114815.
    https://doi.org/10.1016/j.microc.2025.114815
  5. World Health Organization. (n.d.). Mycotoxins and public health implications
    .    https://www.who.int/news-room/fact-sheets/detail/mycotoxins

Gulnara Yuldasheva | Drug Synergy | Women Researcher Award

Published on by Global Diseases Research

Women Researcher Award

Research Profile
Affiliation Scientific Center for Anti-Infective Drug
Country Kazakhstan
Scopus ID 21735405800
Documents 7
Citations 35
h-index 5
Subject Area Drug synergy
Event Global Diseases Research Awards
ORCID 0000-0003-2881-0307

Gulnara Yuldasheva is associated with the Scientific Center for Anti-Infective Drug in Kazakhstan and has contributed to the advancement of research in drug synergy and anti-infective therapeutic studies. Her scholarly work reflects a focused engagement in antimicrobial research, pharmaceutical sciences, and collaborative approaches to disease-related investigations. The academic profile demonstrates measurable research visibility through indexed publications, citations, and international scholarly recognition.[1]

Abstract

The Women Researcher Award recognizes academic and scientific contributions that demonstrate relevance, scholarly consistency, and engagement with emerging challenges in biomedical and pharmaceutical sciences. Gulnara Yuldasheva has contributed to the field of anti-infective drug research with particular attention to drug synergy, antimicrobial investigations, and interdisciplinary pharmaceutical approaches. Her research activities are represented through indexed scientific publications and citation-based academic visibility, indicating active participation in internationally recognized scientific communication.[1][2]

Keywords

  • Drug synergy
  • Anti-infective research
  • Pharmaceutical sciences
  • Biomedical research
  • Women in science
  • Global Diseases Research Awards

Introduction

Research in anti-infective therapeutics continues to play a significant role in addressing global public health challenges related to infectious diseases and antimicrobial resistance. Scientific investigations involving drug synergy provide insights into the combined effects of therapeutic compounds and contribute to the optimization of treatment strategies. Researchers engaged in this domain support evidence-based approaches that may improve clinical outcomes and pharmaceutical innovation.[2]

Gulnara Yuldasheva’s academic profile reflects participation in research initiatives connected with anti-infective drug development and interdisciplinary pharmaceutical studies. Her scholarly contributions demonstrate engagement with research dissemination through indexed databases and internationally accessible scientific literature. Such contributions align with the broader objectives of scientific collaboration and innovation in health-related research environments.[1]

Research Profile

The research profile of Gulnara Yuldasheva is associated with studies in anti-infective pharmacology and drug synergy analysis. Her work has contributed to the understanding of therapeutic interactions and scientific approaches relevant to infectious disease management. Indexed publications and citation metrics indicate continuing scholarly engagement within biomedical and pharmaceutical research communities.[1]

  • Affiliated with the Scientific Center for Anti-Infective Drug.
  • Research specialization includes drug synergy and anti-infective therapeutics.
  • Indexed scientific publications available through Scopus.
  • Recognized through measurable citation impact and academic visibility.
  • Engaged in interdisciplinary biomedical and pharmaceutical studies.

Research Contributions

Research contributions associated with Gulnara Yuldasheva include scientific investigations into anti-infective compounds, synergistic drug interactions, and pharmaceutical research methodologies. Such studies support broader scientific understanding related to therapeutic combinations and their relevance in infectious disease management.[2]

Drug synergy research is important for evaluating combined therapeutic effectiveness, minimizing resistance development, and identifying optimized treatment approaches. Through scholarly publication activity, Yuldasheva has contributed to ongoing scientific discussions in this specialized area of pharmaceutical sciences and biomedical investigation.[3]

Publications

The publication record associated with Gulnara Yuldasheva reflects contributions to scientific literature indexed within internationally recognized academic databases. Her scholarly output demonstrates participation in peer-reviewed communication relevant to anti-infective pharmacology and biomedical research.[1]

  1. Research studies addressing anti-infective therapeutic strategies and drug interaction analysis.
  2. Molecular Modeling of the Anti-HIV Activity Mechanism of Iodine-Containing Drugs Armenicum and FS-1Article link copied! [3]
  3. Iodine-Based Coordination Compounds: A Strategy Toward Antibiotic Potentiation [4]

Research Impact

Research impact may be evaluated through publication indexing, citation activity, and scholarly engagement across scientific platforms. The citation profile associated with Gulnara Yuldasheva demonstrates recognition within academic literature and indicates that her work has contributed to discussions related to pharmaceutical and anti-infective sciences.[1]

The documented h-index and citation metrics reflect measurable academic visibility within the scientific community. Such indicators support the significance of continued research participation and contribution to interdisciplinary biomedical knowledge dissemination.[1]

Award Suitability

The Women Researcher Award within the Global Diseases Research Awards framework recognizes scientific contributions that support research excellence, innovation, and scholarly engagement in health sciences. Gulnara Yuldasheva’s profile demonstrates alignment with these objectives through her involvement in anti-infective drug research, indexed scientific output, and measurable citation impact.[5]

Her academic activities indicate sustained participation in biomedical and pharmaceutical investigations relevant to global health and therapeutic innovation. The combination of publication visibility, research specialization, and international indexing supports the suitability of recognition within a research-oriented academic award context.[1]

Conclusion

Gulnara Yuldasheva has contributed to scientific research associated with anti-infective therapeutics and drug synergy studies through indexed publications and interdisciplinary academic engagement. Her scholarly profile reflects measurable research visibility and participation in pharmaceutical science communication. The academic contributions and citation-based impact presented within this profile demonstrate relevance to contemporary biomedical research and support recognition within the Women Researcher Award category of the Global Diseases Research Awards.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Gulnara Yuldasheva, Author ID 21735405800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=21735405800
  2. World Health Organization. (2023). Antimicrobial resistance and anti-infective therapeutic research.
    https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
  3. Yuldasheva, G. A., Argirova, R., & Ilin, A. I. (2023). Molecular modeling of the anti-HIV activity mechanism of iodine-containing drugs Armenicum and FS-1. ACS Omega, 8(9), 8617–8624
    https://doi.org/10.1021/acsomega.2c07720

  4. Shepilov, D., Askarova, D., Seisembekova, A., Turganbay, S., Jumagaziyeva, A., Bukeyeva, T., Yuldasheva, G., Temir, N., Ivanova, L. N., Zubenko, N., & Kenesheva, S. (2026). Iodine-based coordination compounds: A strategy toward antibiotic potentiation. International Journal of Molecular Sciences, 27(10), 4292.
    https://doi.org/10.3390/ijms27104292

  5. Global Diseases Research Awards. (n.d.). Women Researcher Award recognition and event information.
    https://globaldiseases.org/

Njeumi Felix | Epidemiology | Excellence in Research Award

Published on by Global Diseases Research

Excellence in Research Award

Njeumi Felix
Food and Agriculture Organization of the United Nations
Academic Profile
Affiliation Food and Agriculture Organization of the United Nations
Country Italy
Scopus ID 6506444570
Documents 32
Citations 633
h-index 13
Subject Area Epidemiology
Event Global Diseases Research Awards

Njeumi Felix is an epidemiology researcher and international scientific coordinator associated with the Food and Agriculture Organization of the United Nations. His academic and professional activities are primarily connected to infectious disease surveillance, transboundary animal disease control, and global veterinary public health initiatives. His scholarly work reflects contributions to disease eradication programs, epidemiological assessment methodologies, and collaborative international research activities addressing livestock health management and sustainable agricultural development.[1][2]

Abstract

This academic recognition article provides a scholarly overview of Njeumi Felix and his contributions to epidemiology and infectious disease research. His professional activities include research coordination, epidemiological investigations, and participation in global veterinary health initiatives. His scientific work contributes to disease surveillance systems, veterinary public health frameworks, and collaborative international efforts addressing transboundary animal diseases and livestock health management.[1][3]

Keywords

Epidemiology; Veterinary Science; Infectious Diseases; Disease Surveillance; Peste des Petits Ruminants; Global Disease Eradication; Animal Health; Veterinary Public Health; Transboundary Diseases; International Research Collaboration.

Introduction

Epidemiological research plays a significant role in understanding infectious disease transmission and strengthening international disease prevention systems. Veterinary public health initiatives have become increasingly important due to the global impact of transboundary animal diseases on agricultural economies, livestock productivity, and food security. Njeumi Felix has contributed to these scientific and institutional efforts through research coordination, disease surveillance activities, and international collaborative programs.[2]

Research Profile

The research profile of Njeumi Felix reflects scholarly engagement in epidemiology, disease surveillance, and veterinary health management. His Scopus-indexed publication record includes research articles related to infectious disease risk analysis, surveillance strategies, vaccine assessment methodologies, and global disease control initiatives.[1]

Research Contributions

Njeumi Felix has contributed to research associated with Peste des Petits Ruminants and related transboundary animal diseases. His scientific involvement includes epidemiological modeling, disease risk mapping, surveillance frameworks, and international disease eradication planning activities.[3]

Publications

Selected scientific publications associated with Njeumi Felix include studies addressing epidemiological surveillance, disease risk analysis, vaccine evaluation, and transboundary disease management strategies.[3][4]

Research Impact

The scholarly impact of Njeumi Felix is reflected through citation metrics, collaborative publications, and continued participation in global disease research initiatives. His Scopus profile indicates a significant citation record and measurable academic influence within epidemiology and veterinary science research communities.[1]

Award Suitability

Njeumi Felix demonstrates suitability for recognition within the Global Diseases Research Awards due to his sustained contributions to epidemiology, veterinary public health, and infectious disease research. His scholarly activities reflect international collaboration, scientific productivity, and engagement with disease eradication initiatives relevant to global health priorities.[5]

Conclusion

Njeumi Felix has contributed to the advancement of epidemiological research and international veterinary health initiatives through collaborative scientific work and institutional engagement. His academic profile demonstrates ongoing involvement in disease surveillance, infectious disease management, and evidence-based veterinary public health strategies. The impact of his research supports recognition within scholarly platforms dedicated to global disease research and epidemiological studies.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Njeumi Felix, Author ID 6506444570. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6506444570
  2. Food and Agriculture Organization of the United Nations. (n.d.). Global animal health and disease control initiatives. FAO.
    https://www.fao.org/
  3. Arede, M., Beltrán-Alcrudo, D., Benfield, C., Casal, J., & Njeumi, F. (2024). Risk mapping of Peste des Petits Ruminants virus spread in nine countries surrounding the Black Sea: a spatial multicriteria decision analysis approach. Frontiers in Veterinary Science.
    https://doi.org/10.3389/fvets.2026.1783624
  4. Bodjo, C. S., et al. (2023). Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance. Viruses.
    https://doi.org/10.3390/v17091151
  5. Global Diseases Research Awards. (n.d.). International academic recognition and disease research initiatives.
    https://globaldiseases.org/

Sheng-Xiao Zhang | Rheumatology | Research Excellence Award

Published on by Global Diseases Research
Research Excellence Award
Sheng-Xiao Zhang — Second Hospital of Shanxi Medical University, China
Sheng-Xiao Zhang
Affiliation Second Hospital of Shanxi Medical University
Country China
Scopus ID 56278352600
Documents 134
Citations 1,703
h-index 23
Subject Area Rheumatology
Event Global Diseases Research Awards
ORCID 0000-0003-1341-7588

Sheng-Xiao Zhang is a clinical researcher affiliated with Second Hospital of Shanxi Medical University, China, with a focus on rheumatology and related autoimmune disorders. His scholarly output reflects consistent contributions to clinical studies, translational research, and evidence-based therapeutic approaches. With extensive indexing in Scopus, his work demonstrates significant citation impact and academic visibility within the global medical community. This article summarizes his research profile, publications, and scholarly influence in rheumatology. It further highlights his suitability for the Research Excellence Award under the Global Diseases Research Awards framework, emphasizing academic productivity, citation metrics, and international research engagement in advancing modern rheumatological science globally recognized.

Abstract

Sheng-Xiao Zhang is a clinical researcher affiliated with Second Hospital of Shanxi Medical University, China, with a focus on rheumatology and related autoimmune disorders. His scholarly output reflects consistent contributions to clinical studies, translational research, and evidence-based therapeutic approaches. With extensive indexing in Scopus, his work demonstrates significant citation impact and academic visibility within the global medical community. This article summarizes his research profile, publications, and scholarly influence in rheumatology. It further highlights his suitability for the Research Excellence Award under the Global Diseases Research Awards framework, emphasizing academic productivity, citation metrics, and international research engagement in advancing modern rheumatological science globally recognized.[1]

Keywords

Rheumatology, Autoimmune diseases, Clinical research, Immunology, Shanxi Medical University, Scopus index, Research excellence, Translational medicine.

Introduction

Sheng-Xiao Zhang is a medical academic specializing in rheumatology at Second Hospital of Shanxi Medical University, China. His research focuses on autoimmune diseases, inflammatory mechanisms, and clinical interventions. He has contributed to advancing evidence-based rheumatology practices, with a strong publication record and international academic engagement across multidisciplinary biomedical research communities worldwide collaboration network.[1]

Research Profile

His research profile encompasses clinical rheumatology, immunology, and translational medicine. He has engaged in studies addressing autoimmune pathophysiology, therapeutic optimization, and patient outcomes. His academic work is indexed in Scopus, reflecting strong visibility and citation performance. He participates in collaborative research initiatives aimed at improving global rheumatologic healthcare standards advancement.[2]

Research Contributions

Zhang’s research contributions include clinical investigations into autoimmune disorders, biomarker identification, and therapeutic response evaluation. He has contributed to peer-reviewed studies improving diagnostic accuracy and treatment strategies in rheumatology. His work supports evidence-based medicine and enhances understanding of inflammatory disease progression within diverse patient populations across international clinical settings globally. [3]

Publications

His publication record includes peer-reviewed articles in rheumatology and related biomedical fields. These works cover autoimmune disease mechanisms, clinical treatment outcomes, and translational research findings. His Scopus-indexed outputs demonstrate consistent scholarly productivity and contribute to the advancement of clinical knowledge in immunological and musculoskeletal disorders within global research databases networks.[4]

Research Impact

His research impact is reflected through citations, collaborative studies, and contributions to advancing rheumatology research. With an h-index of 23 and over 1,700 citations, his work demonstrates significant academic influence. His studies are widely referenced in clinical research, supporting improved understanding of autoimmune disease management across international scientific communities globally.[3]

Award Suitability

Sheng-Xiao Zhang is considered suitable for the Research Excellence Award due to his strong academic record in rheumatology, significant citation impact, and consistent publication output. His contributions to clinical research and international collaboration align with the objectives of the Global Diseases Research Awards recognizing scientific excellence and innovation globally recognized.[1]

Conclusion

This article highlights Sheng-Xiao Zhang’s academic profile, emphasizing his contributions to rheumatology research, clinical advancements, and scientific publications. His work demonstrates significant scholarly impact and international relevance. Continued research engagement is expected to further enhance his contributions to global medical science and rheumatologic innovation in future academic research landscapes globally.

References

1. Elsevier. (n.d.). Scopus author details: Sheng-Xiao Zhang, Author ID 56278352600. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=56278352600

2. Qi, X.-Y., Liu, M.-X., Jiang, X.-J., Gao, T., Xu, G.-Q., Zhang, H.-Y., Su, Q.-Y., Du, Y., Luo, J., & Zhang, S.-X. (2025). Gut microbiota in rheumatoid arthritis: Mechanistic insights, clinical biomarkers, and translational perspectives. Autoimmunity Reviews.
https://doi.org/10.1016/j.autrev.2025.103912

3. Zhang, W., Wang, C., Fu, T., Zhang, S., & Tian, F. (2025). CD4+ T lymphocyte and cytokine profiles in depressive disorders. BMC Psychiatry.
https://doi.org/10.1186/s12888-025-07344-8

4. Su, Q.-Y., Zhang, J.-T., Gao, H.-J., Zhang, Y., Luo, J., Cao, T.-Y., Yang, M.-Y., & Zhang, S.-X. (2025). Mechanism and clinical utility of abatacept in the treatment of rheumatoid arthritis. Expert Opinion on Drug Metabolism & Toxicology.
https://doi.org/10.1080/14740338.2025.2505542

5. Fu, T., Zhang, W., Zhang, S., & Tian, F. (2025). The impact of sleep on the Th17/Treg axis and cytokine levels in patients with major depressive disorder. Neuroscience Research.
https://doi.org/10.1016/j.neures.2025.104927